How to Create a Sliding Scale Insulin Chart with Corrections
Do not use sliding scale insulin (SSI) alone as your primary approach—instead, create a correction insulin scale that is integrated with scheduled basal-bolus insulin therapy, as SSI alone is associated with poor glycemic control and is condemned by current guidelines 1, 2.
Key Distinction: Correction Insulin vs. Sliding Scale Insulin
The terminology matters here:
Sliding Scale Insulin (SSI): A reactive, outdated approach where insulin is given only after hyperglycemia occurs, without regard to meals, existing insulin, or individual sensitivity. This approach is strongly discouraged 1, 2.
Correction Insulin: A component of scheduled insulin therapy where rapid-acting insulin is administered based on pre-meal glucose readings (or every 4-6 hours if NPO), used in combination with basal and/or prandial insulin 2.
Creating a Correction Insulin Scale
Step 1: Calculate the Correction Factor (Insulin Sensitivity Factor)
Use the 1800 Rule for rapid-acting insulin analogues (lispro, aspart, glulisine):
- Correction Factor = 1800 ÷ Total Daily Dose (TDD) of insulin
Use the 1500 Rule for regular (short-acting) human insulin:
Example: If a patient requires 50 units of insulin per day:
- With rapid-acting: 1800 ÷ 50 = 36 mg/dL per unit
- This means 1 unit of insulin will lower blood glucose by approximately 36 mg/dL
Step 2: Determine the Target Blood Glucose
Set your target glucose (typically 100-140 mg/dL for most hospitalized patients).
Step 3: Create the Correction Dose Table
Formula: Correction dose = (Current BG - Target BG) ÷ Correction Factor
Create a table with incremental glucose ranges:
| Blood Glucose (mg/dL) | Correction Dose (units) |
|---|---|
| 141-180 | 1 unit |
| 181-220 | 2 units |
| 221-260 | 3 units |
| 261-300 | 4 units |
| 301-340 | 5 units |
| >340 | 6 units + notify MD |
This example assumes a correction factor of ~40 mg/dL per unit
Integrating Correction Insulin into a Complete Regimen
For Patients Eating Regular Meals (Basal-Bolus Approach)
Calculate Total Daily Dose (TDD):
- Insulin-naive patients: 0.3-0.5 units/kg/day 1
- Lower doses (0.3 units/kg): For elderly (>65 years), renal failure, poor oral intake 1
- Patients on home insulin ≥0.6 units/kg: Reduce by 20% to prevent hypoglycemia 1
Distribute the TDD:
- 50% as basal insulin (given once or twice daily)
- 50% as prandial insulin (divided equally before 3 meals)
- Add correction insulin using your calculated scale before each meal 2
Example for 70 kg patient:
- TDD = 0.4 × 70 = 28 units/day
- Basal: 14 units (glargine once daily)
- Prandial: ~5 units before each meal (rapid-acting)
- Correction: Add per scale based on pre-meal glucose
For Patients with Mild Hyperglycemia or Poor Oral Intake (Basal-Plus Approach)
- Basal insulin only: 0.1-0.25 units/kg/day 1
- Correction insulin: Every 4-6 hours (if NPO) or before meals 2
- This approach reduces hypoglycemia risk in patients with glucose <200 mg/dL 1
For Patients Not Eating (NPO)
- Basal insulin: Continue at reduced dose
- Hold prandial insulin
- Correction insulin only: Every 4-6 hours based on glucose checks 2
Critical Pitfalls to Avoid
Never use SSI alone in patients with known diabetes—this leads to persistent hyperglycemia and worse outcomes 1, 2
Never use SSI alone in type 1 diabetes—these patients require basal insulin at all times 1
Adjust for hypoglycemia risk: Lower all doses by 20-50% in elderly, renal failure, or unpredictable oral intake 1
Premixed insulins (70/30) are NOT recommended in hospitals due to unacceptably high hypoglycemia rates 1
The only acceptable use of SSI alone is in patients without diabetes who have mild stress hyperglycemia 1
Documentation Format
Your order set should include:
- Basal insulin: [Type] [Dose] units [Frequency]
- Prandial insulin: [Type] [Dose] units before meals
- Correction scale: [Type of rapid-acting insulin] per scale:
- BG 141-180: 1 unit
- BG 181-220: 2 units
- (Continue as calculated above)
- Glucose monitoring: Before meals and bedtime (or every 4-6 hours if NPO)
The basal-bolus approach with integrated correction dosing has consistently demonstrated superior glycemic control and reduced complications compared to SSI alone 1, though it carries a 12-30% risk of mild hypoglycemia that requires vigilant monitoring 1.